69 drugs reach their earliest generic-entry date in 2037

Jan 2037 · 3

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Giapreza · 2 strengths angiotensin ii acetate	angiotensin ii acetate	La Jolla Pharma	209360	6 Jan 2037	patent, carve-out possible
Miudella copper	copper	Sebela Womens Hlth	218201	23 Jan 2037	patent
Modeyso dordaviprone hydrochloride	dordaviprone hydrochloride	Chimerix	219876	30 Jan 2037	patent, carve-out possible

Feb 2037 · 14

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Entresto Sprinkle · 2 strengths sacubitril; valsartan	sacubitril; valsartan	Novartis	218591	2 Feb 2037	patent
Lonsurf · 2 strengths tipiracil hydrochloride; trifluridine	tipiracil hydrochloride; trifluridine	Taiho Oncology	207981	3 Feb 2037	patent
Relexxii · 7 strengths methylphenidate hydrochloride	methylphenidate hydrochloride	Osmotica Pharm Us	216117	3 Feb 2037	patent
Goprelto cocaine hydrochloride	cocaine hydrochloride	Lxo Ireland	209963	7 Feb 2037	patent
Numbrino cocaine hydrochloride	cocaine hydrochloride	Omnivium Pharms	209575	7 Feb 2037	patent
Procysbi · 2 strengths cysteamine bitartrate	cysteamine bitartrate	Horizon	203389	16 Feb 2037	patent
Procysbi · 2 strengths cysteamine bitartrate	cysteamine bitartrate	Horizon	213491	16 Feb 2037	patent
Vijoice alpelisib	alpelisib	Novartis	218466	17 Feb 2037	patent, carve-out possible
Vijoice · 3 strengths alpelisib	alpelisib	Novartis	215039	17 Feb 2037	patent, carve-out possible
Ibrance · 3 strengths palbociclib	palbociclib	Pfizer	212436	19 Feb 2037	patent
Xtandi · 2 strengths enzalutamide	enzalutamide	Astellas	213674	23 Feb 2037	patent, carve-out possible
Xtandi enzalutamide	enzalutamide	Astellas	203415	23 Feb 2037	patent, carve-out possible
Firdapse amifampridine phosphate	amifampridine phosphate	Catalyst Pharms	208078	25 Feb 2037	patent
Cequa cyclosporine	cyclosporine	Sun Pharm	210913	28 Feb 2037	patent

Mar 2037 · 1

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Esbriet · 2 strengths pirfenidone	pirfenidone	Legacy	208780	28 Mar 2037	patent

Apr 2037 · 3

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Terlivaz terlipressin acetate	terlipressin acetate	Mallinckrodt Ireland	022231	5 Apr 2037	patent, carve-out possible
Drizalma Sprinkle · 4 strengths duloxetine hydrochloride	duloxetine hydrochloride	Sun Pharm	212516	13 Apr 2037	patent
Aqneursa levacetylleucine	levacetylleucine	Intrabio	219132	19 Apr 2037	patent, carve-out possible

May 2037 · 6

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Definity perflutren	perflutren	Lantheus Medcl	021064	4 May 2037	patent, carve-out possible
Definity Rt perflutren	perflutren	Lantheus Medcl	021064	4 May 2037	patent, carve-out possible
Yutrepia · 4 strengths treprostinil sodium	treprostinil sodium	Liquidia Tech	213005	5 May 2037	patent
Vitrakvi larotrectinib sulfate	larotrectinib sulfate	Bayer Healthcare	211710	16 May 2037	patent, carve-out possible
Vitrakvi · 2 strengths larotrectinib sulfate	larotrectinib sulfate	Bayer Hlthcare	210861	16 May 2037	patent, carve-out possible
Tepadina And Sodium Chloride · 2 strengths thiotepa	thiotepa	Adienne Sa	208264	31 May 2037	patent

Jun 2037 · 7

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Ensacove · 2 strengths ensartinib hydrochloride	ensartinib hydrochloride	Xcovery	218171	1 Jun 2037	patent
Uptravi · 10 strengths selexipag	selexipag	Actelion	207947	1 Jun 2037	patent
Akynzeo fosnetupitant chloride hydrochloride; palonosetron hydrochloride	fosnetupitant chloride hydrochloride; palonosetron hydrochloride	Helsinn Hlthcare	210493	2 Jun 2037	patent
Atorvaliq atorvastatin calcium	atorvastatin calcium	Cmp Dev Llc	213260	7 Jun 2037	patent
Pylarify piflufolastat f-18	piflufolastat f-18	Progenics Pharms Inc	214793	9 Jun 2037	patent
Pylarify Truvu piflufolastat f-18	piflufolastat f-18	Aphelion	220089	9 Jun 2037	patent
Miebo perfluorohexyloctane	perfluorohexyloctane	Bausch And Lomb Inc	216675	21 Jun 2037	patent, carve-out possible

Jul 2037 · 4

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Saxenda liraglutide	liraglutide	Novo	206321	9 Jul 2037	patent
Victoza liraglutide	liraglutide	Novo Nordisk Inc	022341	9 Jul 2037	patent
Inlyta · 2 strengths axitinib	axitinib	Pf Prism Cv	202324	12 Jul 2037	patent
Calcium Gluconate In Sodium Chloride · 3 strengths calcium gluconate	calcium gluconate	Hq Spclt Pharma	210906	25 Jul 2037	patent

Aug 2037 · 5

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Sutab magnesium sulfate; potassium chloride; sodium sulfate	magnesium sulfate; potassium chloride; sodium sulfate	Azurity	213135	4 Aug 2037	patent
Sohonos · 4 strengths palovarotene	palovarotene	Ipsen	215559	16 Aug 2037	patent, carve-out possible
Qlosi pilocarpine hydrochloride	pilocarpine hydrochloride	Orasis Pharms	217836	18 Aug 2037	patent
Zurzuvae · 3 strengths zuranolone	zuranolone	Biogen	217369	23 Aug 2037	patent
Zoryve · 3 strengths roflumilast	roflumilast	Arcutis	215985	25 Aug 2037	patent, carve-out possible

Sep 2037 · 5

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Amzeeq minocycline hydrochloride	minocycline hydrochloride	Journey	212379	8 Sep 2037	patent, carve-out possible
Nuplazid pimavanserin tartrate	pimavanserin tartrate	Acadia Pharms Inc	207318	23 Sep 2037	patent
Foundayo · 6 strengths orforglipron calcium	orforglipron calcium	Eli Lilly And Co	220934	26 Sep 2037	patent
Fleqsuvy baclofen	baclofen	Azurity	215602	29 Sep 2037	patent
Orgovyx relugolix	relugolix	Sumitomo Pharma Am	214621	29 Sep 2037	patent, carve-out possible

Oct 2037 · 5

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Filspari · 2 strengths sparsentan	sparsentan	Travere	216403	13 Oct 2037	patent, carve-out possible
Xerava · 2 strengths eravacycline dihydrochloride	eravacycline dihydrochloride	Tetraphase Pharms	211109	19 Oct 2037	patent
Edurant Ped rilpivirine hydrochloride	rilpivirine hydrochloride	Janssen Prods	219016	23 Oct 2037	patent
Nuzyra omadacycline tosylate	omadacycline tosylate	Paratek Pharms	209816	31 Oct 2037	patent, carve-out possible
Nuzyra omadacycline tosylate	omadacycline tosylate	Paratek Pharms	209817	31 Oct 2037	patent, carve-out possible

Nov 2037 · 1

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Fluorescein Sodium And Benoxinate Hydrochloride benoxinate hydrochloride; fluorescein sodium	benoxinate hydrochloride; fluorescein sodium	Bausch Lomb Ireland	211039	15 Nov 2037	patent

Dec 2037 · 15

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Vosevi sofosbuvir; velpatasvir; voxilaprevir	sofosbuvir; velpatasvir; voxilaprevir	Gilead Sciences Inc	209195	1 Dec 2037	patent
Lupkynis voclosporin	voclosporin	Aurinia	213716	7 Dec 2037	patent, carve-out possible
Glyxambi · 2 strengths empagliflozin; linagliptin	empagliflozin; linagliptin	Boehringer Ingelheim	206073	8 Dec 2037	patent
Jentadueto · 3 strengths linagliptin; metformin hydrochloride	linagliptin; metformin hydrochloride	Boehringer Ingelheim	201281	8 Dec 2037	patent
Jentadueto Xr · 2 strengths linagliptin; metformin hydrochloride	linagliptin; metformin hydrochloride	Boehringer Ingelheim	208026	8 Dec 2037	patent
Tradjenta linagliptin	linagliptin	Boehringer Ingelheim	201280	8 Dec 2037	patent
Trijardy Xr · 4 strengths empagliflozin; linagliptin; metformin hydrochloride	empagliflozin; linagliptin; metformin hydrochloride	Boehringer Ingelheim	212614	8 Dec 2037	patent
Trikafta (Copackaged) elexacaftor, ivacaftor, tezacaftor; ivacaftor	elexacaftor, ivacaftor, tezacaftor; ivacaftor	Vertex Pharms Inc	217660	8 Dec 2037	patent
Azstarys · 3 strengths dexmethylphenidate hydrochloride; serdexmethylphenidate chloride	dexmethylphenidate hydrochloride; serdexmethylphenidate chloride	Commave Sub	212994	9 Dec 2037	patent
Zykadia ceritinib	ceritinib	Novartis	211225	13 Dec 2037	patent, carve-out possible
Micafungin In Sodium Chloride 0.9% · 3 strengths micafungin sodium	micafungin sodium	Baxter Hlthcare Corp	216142	15 Dec 2037	patent
Hemady dexamethasone	dexamethasone	Dexcel	211379	18 Dec 2037	patent
Gloperba colchicine	colchicine	Scilex Pharms	210942	20 Dec 2037	patent
Auvi-Q · 2 strengths epinephrine	epinephrine	Kaleo Inc	201739	21 Dec 2037	patent
Bludigo indigotindisulfonate sodium	indigotindisulfonate sodium	Provepharm Sas	216264	23 Dec 2037	patent